Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

BA-BE Studies: SOP for Ensuring Adequate Staffing in Clinical Units – V 2.0

Posted on By

BA-BE Studies: SOP for Ensuring Adequate Staffing in Clinical Units – V 2.0

Standard Operating Procedure for Ensuring Adequate Staffing in Clinical Units during BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/138/2025
Supersedes SOP/BA-BE/138/2022
Page No. Page 1 of 10
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the procedure for determining, assigning, and verifying adequate staffing levels at clinical units involved in the conduct of BA/BE studies to ensure subject safety, compliance with protocol requirements, and uninterrupted trial operations.

2. Scope

This SOP applies to all staff planning, resourcing, and operations activities at the clinical site, including project managers, medical officers, nurses, pharmacists,

phlebotomists, and support staff during the execution of BA/BE studies.

3. Responsibilities

  • Project Manager: Coordinates overall staff planning and ensures alignment with study timelines.
  • Clinical Operations Lead: Reviews staffing rosters and deployment plans.
  • Human Resource (HR) Department: Provides qualified personnel as per resource request.
  • QA Officer: Audits staffing logs and verifies role-based training and GCP compliance.

4. Accountability

The Head of Clinical Operations is accountable for ensuring that the clinical unit is staffed adequately in accordance with ICH-GCP, protocol specifications, and regulatory expectations.

See also  BA-BE Studies: SOP for Managing Subject Dropouts and Replacements in BA/BE Studies - V 2.0

5. Procedure

5.1 Staffing Needs Assessment

  1. Upon receipt of the approved study protocol and clinical calendar, the Project Manager shall initiate staffing assessment using Annexure-1: Staffing Requirement Worksheet.
  2. Consider the following:
    • Study design (e.g., crossover/fed/fasted)
    • Number of subjects per group and period
    • Sampling points and critical time intervals
    • Dosing days and washout periods
    • Weekday vs. weekend workload
  3. Calculate required Full-Time Equivalents (FTEs) per role (nurse, phlebotomist, physician, etc.).

5.2 Preparation of Staff Roster

  1. Clinical Operations Lead shall develop the Staff Duty Roster using Annexure-2.
  2. Rosters must ensure:
    • Minimum of 1 physician per 20 subjects on dosing day
    • 1 nurse per 10 subjects for pre- and post-dose monitoring
    • 1 phlebotomist per 8–10 subjects for intensive sampling windows
  3. Include shift timings, names, responsibilities, and standby personnel.

5.3 Staff Qualification and Training Verification

  1. Only personnel trained in GCP, protocol procedures, and their assigned responsibilities shall be deployed.
  2. Maintain training records in Annexure-3: Study Staff Qualification Log.
  3. Cross-train team members for overlapping roles (e.g., phlebotomy + nursing support) for flexibility.

5.4 Contingency Planning

  1. Prepare Annexure-4: Staff Backup Roster in case of sudden absenteeism.
  2. Ensure availability of on-call physicians and nurses, especially for overnight stays and emergencies.
  3. Maintain standby staff pool for peak activities like dosing, ECGs, or PK sampling.
See also  BA-BE Studies: SOP for Trial Registration with EudraCT - V 2.0

5.5 Daily Briefing and Attendance

  1. Conduct pre-activity briefing at least 1 hour before each dosing or sampling session.
  2. Use Annexure-5: Staff Attendance Register to document presence and duty start times.
  3. Communicate role assignments, safety instructions, and contact protocols during briefing.

5.6 Staff Performance Monitoring

  1. Designate team leads to supervise each function (medical, sample handling, data recording).
  2. Document any deviations from assigned responsibilities or delays in Annexure-6: Staff Performance Log.
  3. Report repeated issues to HR and QA for retraining or reassignment decisions.

5.7 Post-Study Staff Debrief and Feedback

  1. Conduct a post-study review meeting to discuss staff performance, workload challenges, and process gaps.
  2. Record feedback using Annexure-7: Staff Feedback Form and archive with the trial master file.

6. Abbreviations

  • BA/BE: Bioavailability / Bioequivalence
  • FTE: Full-Time Equivalent
  • GCP: Good Clinical Practice
  • QA: Quality Assurance
  • HR: Human Resources

7. Documents

  1. Staffing Requirement Worksheet – Annexure-1
  2. Staff Duty Roster – Annexure-2
  3. Study Staff Qualification Log – Annexure-3
  4. Staff Backup Roster – Annexure-4
  5. Staff Attendance Register – Annexure-5
  6. Staff Performance Log – Annexure-6
  7. Staff Feedback Form – Annexure-7

8. References

  • ICH E6(R2) – Good Clinical Practice
  • Schedule Y – Drugs and Cosmetics Rules, India
  • WHO Handbook for Good Clinical Research Practice
See also  BA-BE Studies: SOP for Labelling of Biological Samples - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Staffing Requirement Worksheet

Role FTE Needed Based On
Phlebotomist 4 40 subjects × 10 time points

Annexure-2: Staff Duty Roster

Name Role Shift Contact
Rajesh Kumar Nurse 06:00–14:00 Ext. 101

Annexure-3: Study Staff Qualification Log

Name Role GCP Trained Protocol Trained
Sunita Reddy Pharmacist Yes Yes

Annexure-4: Staff Backup Roster

Role Primary Staff Backup Staff
Medical Officer Dr. Ajay Sharma Dr. Neha K.

Annexure-5: Staff Attendance Register

Date Name Role In-Time Out-Time Remarks
17/04/2025 Ravi Mishra Phlebotomist 05:55 14:10 On Duty

Annexure-6: Staff Performance Log

Date Staff Name Issue Observed Action Taken
16/04/2025 Priya Sinha Late arrival Verbal warning

Annexure-7: Staff Feedback Form

Name Role Feedback Suggestions
Akshay Patel Nurse Sampling was well managed Need more breaks during long shifts

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP release Site Preparedness SOPs QA Head
17/04/2025 2.0 Expanded staffing ratios, annexures, and performance tracking Audit feedback and operational revision QA Head
BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

Post navigation

Previous Post: Analytical Method Development: Refractive Index Method Development – V 2.0
Next Post: API Manufacturing: SOP for Preparation of HPLC Mobile Phase – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version